News | Proton Therapy | September 02, 2015

Southern Hemisphere’s First Proton Therapy Unit Developing in South Australia

Clinicians working with Philips to bring more precise radiation therapy option to 600-800 patients annually  

SAHMRI, proton therapy unit, South Australia, first in Southern Hemisphere

September 2, 2015 — Significant national and international momentum is building to include a proton therapy unit as part of the planned expansion of SAHMRI, South Australia’s Health and Medical Research Institute. It would be the first facility in the Southern Hemisphere to deliver proton therapy.

Cancer specialist and former CEO of Cancer Council Australia Prof. Ian Oliver said South Australia was the obvious choice to create a Proton Therapy Unit that would service Australia and the region.

“There have been groups in New South Wales and Victoria also considering a bid to establish a proton facility, but South Australia is the furthest ahead,” he said.

“Because SAHMRI already operates a cyclotron, it already has highly relevant experience in operating a particle accelerator as would be required for proton therapy,” he added.

For proton therapy, a cyclotron accelerates the protons almost to the speed of light, and they are then directed through a probe to release their energy at the tumor site.

“The treatment itself takes less than two minutes,” said Prab Takhar, director of the molecular imaging and therapy research unit at SAHMRI.

Radiation oncologists across South Australia are collaborating with Philips on development of the center, which will expand the number of trained technicians available when the center opens.

The SAHMRI proton therapy unit will reportedly be able to treat 600-800 patients per year.

For more information: www.sahmri.com

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...